RHU and NISM Sign MoU to Strengthen Financial Market Education

Published on: March 27, 2026

Swami Rama Himalayan University (SRHU), Jolly Grant, through its School of Management Studies, has signed a Memorandum of Understanding (MoU) with the National Institute of Securities Markets (NISM), Mumbai, to enhance financial education and career-oriented training for students. The collaboration is aimed at equipping students with professional skills and a deeper understanding of global financial markets.

The MoU was formally signed by SRHU Registrar Commander Challa Venkateshwara (Retd.) and Ms. Barkha Nigam from NISM. Under this partnership, students will gain opportunities to pursue professional certification programmes in areas such as derivatives, mutual funds, investment advisory, research analysis, portfolio management services, merchant banking, and the fundamentals of securities markets.

Speaking on the occasion, Vice Chancellor of SRHU, Dr. Rajendra Dobhal, said that this collaboration will help students move beyond conventional classroom learning and prepare them to become industry-ready professionals. He noted that association with NISM will enable students to gain practical insights into financial markets, opening up better employment prospects and encouraging entrepreneurship and informed investment practices.

Dr. Dobhal further added that the initiative will also include Faculty Development Programmes, which will enhance the knowledge and professional capabilities of faculty members. This will help strengthen the quality of teaching and ensure that the curriculum remains aligned with evolving industry requirements.

Faculty members from the School of Management Studies, including Dr. Taruna Gautam, Dr. Rajneesh Klair, and Dr. Apoorv Trivedi, were also present on the occasion.

WhatsApp Image 2026-03-28 at 16.48.37 (1)
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.